U.S. Energy Services Stock News

Outlook Therapeutics stock has had a very weak run over the past five years, yet recent FDA approval for its lead drug has put fresh attention on whether the current US$1.00 share price is justified given the broader valuation checks. The share price has declined 97.9% over the past five years, which means long term holders have absorbed very heavy losses that set a low base for any future rerating. The recent FDA approval of LYTENAVA for wet age related macular degeneration can support...

Sunrun stock is trading around US$9.47 after a very steep 82.3% decline over the past 5 years, and the valuation checks send a mixed message about whether that reset has gone far enough. Over 5 years, Sunrun shareholders have seen the share price fall 82.3%. This puts the current valuation in the context of a long and painful reset rather than a short term swing. Future demand for residential solar and Sunrun's ability to turn that demand into steady cash flows can support the current price...

Earlier this week, Jefferies analysts said Flutter Entertainment may be at an inflection point as worries about prediction market competition ease, citing recovering online sports betting trends and minimal evidence of share loss. Jefferies also highlighted potential new profit streams from market-making, FanDuel Predicts and regulatory leverage tied to prediction markets, which could reshape how investors view Flutter’s earnings mix. Next, we’ll explore how Jefferies’ focus on new profit...

Markets are searching for companies that can keep growing even as inflation, energy costs and central bank decisions pull in different directions. The Fast Growing Stocks With High Insider Ownership screener focuses on businesses where analysts and management see room for further expansion, and where insiders have meaningful skin in the game. That combination can appeal if you want growth that is supported by both external research and internal conviction. In this article you will see 3...

Motorola Solutions (MSI) is back in focus as investors look ahead to its upcoming second quarter 2026 earnings release, with growing attention on expected earnings and revenue figures as well as the company’s record of beating past estimates. See our latest analysis for Motorola Solutions. At a latest share price of US$434.20, Motorola Solutions has recently gained momentum, with a 7 day share price return of 7.39% and a year to date share price return of 13.96%. The 5 year total shareholder...

Amneal Pharmaceuticals (AMRX) has drawn fresh attention after receiving U.S. Food and Drug Administration approval for additional strengths and vial sizes of its iohexol injection, which expands its radiographic contrast agent offering. See our latest analysis for Amneal Pharmaceuticals. The FDA approval arrives at a time when Amneal Pharmaceuticals’ share price momentum is strong, with a 30 day share price return of 10.47% and a year to date share price return of 50.87%, alongside a 1 year...

Trinity Capital (TRIN) was removed from the NASDAQ Composite Index on 24 July 2026. This event can prompt index tracking funds and benchmarked portfolios to adjust holdings and reassess exposure to the stock. See our latest analysis for Trinity Capital. Trinity Capital's removal from the NASDAQ Composite comes after a period where the share price rose 16.74% year to date and the 1 year total shareholder return reached 35.24%. This points to momentum that has built over a longer horizon, even...

Tecnoglass stock has given shareholders a strong 150.1% return over the past 5 years, yet its recent slide and mixed valuation checks raise questions about how the current price stacks up against fundamentals. After a 40.9% decline over the past year and a year to date return that is down 13.8%, the focus now is whether the recent level around US$44.88 still offers value or mainly reflects past gains. Over 5 years Tecnoglass has returned 150.1%, which puts the recent share price weakness...

The latest Stellantis earnings update shows how quickly sentiment can swing when results and expectations do not line up. Net profit moved to €293 million in Q2 from a loss of €1.87 billion a year earlier, and adjusted operating income reached €773 million. However, the stock still fell as much as 8% on the day because the figure came in below the €914 million consensus. That kind of reaction can ripple across North American auto manufacturers. This article looks at 3 stocks exposed to that...

In recent weeks, a series of partner announcements has expanded Walmart’s assortment and ecosystem exposure, from Kate Farms’ High Protein Nutrition Shake rollout across more than 6,800 Walmart and CVS locations to Edible Garden’s fresh herb expansion in Mid-Atlantic stores and Final Boss Sour’s planned entry into Walmart’s shelves. At the same time, integration into tools like Shirofune’s Walmart Connect interface and a reported investor rotation toward defensive retailers underline how...

The Federal Trade Commission, Utah, and Los Angeles County filed a lawsuit against Hims & Hers Health (NYSE:HIMS) alleging unauthorized sharing of sensitive health data and deceptive billing practices. The complaint focuses on how the company handled patient information on its telehealth platform and how subscriptions and cancellations were billed and processed. The action highlights potential regulatory and reputational risks for Hims & Hers Health that investors may weigh when assessing...

The latest 1,000 point drop in the Dow after the Federal Reserve held interest rates steady has put value stocks back under the spotlight. With inflation still above target and U.S. oil prices near US$85 per barrel, many investors are taking a fresh look at large U.S. companies that already trade on lower price ratios and have some dividend history. This article focuses on three U.S. Large Cap Value Stocks from our screener that appear more directly exposed to the current rate and oil...

AAR Corp. recently reported fourth-quarter 2026 results showing sales of US$928 million and net income of US$50.7 million, alongside a completed US$107.54 million share repurchase program that retired 2,429,700 shares under its 2021 authorization. The company also filed an omnibus shelf registration covering multiple security types, giving it broad flexibility to raise capital after a year in which full-year earnings per share from continuing operations increased markedly. We’ll now examine...

Michael Kneeland, former CEO and current non executive chairman of United Rentals, has joined the board of directors of NYSE:XPO. Kneeland brings leadership experience in industrial services, equipment rental and logistics related businesses. This appointment marks a recent change in XPO's board composition and governance structure. XPO operates in freight transportation and logistics, a sector that depends heavily on operational efficiency, capital discipline and consistent service...

The Morning Bull - US Market Morning Update Thursday, Jul, 30 2026 US market stock futures are pointing slightly higher this morning, with E-mini S&P 500 contracts up about 0.3%, as investors weigh interest rate risks and energy prices. The US 10 year Treasury yield is steady ahead of the Federal Reserve meeting, where markets see roughly a one in three chance of a rate hike now and about 80% odds in September. That reflects concern that Middle East related oil price moves could keep...

Republic Services (RSG) is back in focus after workers represented by Teamsters Local 104 unanimously voted to authorize a strike and filed an unfair labor practice charge, raising fresh questions around labor relations and potential operational risk. See our latest analysis for Republic Services. Republic Services shares recently closed at US$218.91, with short term momentum reflected in a 1 day share price return of 1.05% and a 90 day share price return of 4.63%, while the 1 year total...

Recent analyst reports on Atour Lifestyle Holdings (NasdaqGS:ATAT) have focused on upward revisions to earnings estimates and a Zacks Rank #1. This has drawn fresh attention to the stock within the leisure and recreation services sector. See our latest analysis for Atour Lifestyle Holdings. Atour Lifestyle Holdings has seen short term momentum pick up, with a 12.30% 7 day share price return and 9.31% 30 day share price return, although the share price is still down 11.39% year to date. The 3...

In the past week, uniQure N.V. reported Q2 2026 results showing revenue of US$5.84 million alongside a much larger quarterly net loss of US$81.06 million, while also filing a US$12.83 million shelf registration for 350,000 ordinary shares tied to its employee share plan. At the same time, the company advanced its regulatory plans for AMT-130 in Huntington’s disease and highlighted promising early data in epilepsy and Fabry programs, framing a contrast between widening losses and progress in...

Textron (TXT) is back in focus after its latest update combined several key signals. The company reported second quarter results, reaffirmed full year 2026 earnings guidance, and confirmed completion of a planned share repurchase tranche. See our latest analysis for Textron. Textron's recent earnings beat, reiterated 2026 guidance and completion of its buyback tranche came as the share price fell 4.8% on the day and 10.7% over 90 days, while the 1 year total shareholder return of 9.8% points...

Novanta (NasdaqGS:NOVT) has completed its acquisition of Riverpoint Medical. The deal significantly increases Novanta's exposure to the medical consumables market. Management expects the transaction to approximately double recurring medical consumables revenue. Novanta focuses on precision photonics, vision and motion technologies used in medical and advanced industrial applications. With Riverpoint Medical now under its umbrella, the company gains a larger footprint in medical consumables,...

Owens Corning recently announced that Jonathan Collins will become Executive Vice President and Chief Financial Officer on August 10, 2026, succeeding Todd Fister, who moves into the newly defined role of President and Chief Operating Officer to oversee enterprise initiatives and operational execution. The appointment brings in a finance leader with experience integrating generative AI and managing complex transformations, while freeing Fister to concentrate on aligning operations and...

In late July 2026, SS&C Technologies Holdings, Inc. filed a US$779 million shelf registration for 10,000,000 common shares tied to an ESOP-related offering, shortly after reporting second-quarter 2026 revenue of US$1,695.7 million and net income of US$234.8 million, both higher than the prior year. The earnings release also showed higher basic and diluted earnings per share from continuing operations for both the quarter and first half of 2026, pointing to improved profitability alongside...

Eton Pharmaceuticals has submitted a Prior Approval Supplement to the FDA seeking to extend KHINDIVI’s hydrocortisone oral solution label to younger pediatric patients with adrenocortical insufficiency, beyond its current approval for those aged five and older. This move, backed by bioequivalence data versus ALKINDI SPRINKLE, could broaden treatment options in a rare disease population where Eton estimates about 10,000 U.S. pediatric patients. With KHINDIVI already the only FDA-approved...

Pentair stock has fallen sharply this year, yet the company still screens as undervalued on several key checks, including an intrinsic value estimate that sits well above the current share price. With sentiment hit by legal investigations and weaker trading in parts of the business, investors are weighing whether the current discount fairly reflects the risks now in play. Year to date, Pentair shares are down 36.9%, which means current holders have taken a sizeable hit and new investors are...